Form 4: Astera Labs CFO Sells Shares for Tax Obligations

Astera Labs' Chief Financial Officer, Michael Truett Tate, sold 12,001 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Summary

• Michael Truett Tate, Chief Financial Officer of Astera Labs, Inc. (ALAB), sold a total of 12,001 shares of common stock on February 17, 2026.
• The sales were non-discretionary and mandated by an issuer election to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units.
• The shares were sold in multiple transactions at weighted average prices ranging from $122.1569 to $126.34 per share.
• Following these transactions, Michael Truett Tate directly holds 192,083 shares of common stock.
• Additionally, 450,281 shares are indirectly owned by the Tate Trust, for which the Reporting Person is a trustee, disclaiming beneficial ownership except for pecuniary interest.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral event. While it reduces insider ownership, it's a non-discretionary sale for tax purposes, which is a common and expected part of executive compensation.

Negatives

• The sale of 12,001 shares by a key executive, even for tax purposes, represents a reduction in direct insider ownership.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Astera Labs' future performance or strategic direction.

Management Comments

• The sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover', and does not represent a discretionary trade by the Reporting Person.

Industry Context

StockSavvy.ai notes that 'sell to cover' transactions are a common and expected occurrence for executives receiving equity compensation, particularly restricted stock units (RSUs), as they vest. This type of transaction is generally not indicative of an executive's sentiment about the company's future prospects, unlike discretionary sales.

Comparison to Industry Standards

• This 'sell to cover' transaction aligns with standard industry practices for managing tax liabilities associated with equity compensation. Many technology companies, including peers like Nvidia (NVDA) and Broadcom (AVGO), structure RSU vesting with similar tax withholding mechanisms for their executives.

Related Party Transactions

• 450,281 shares are indirectly owned by the Tate 1997 Living Trust Dated April 24, 1997 (the 'Tate Trust'), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

Stakeholder Impact

• Shareholders: The transaction is unlikely to have a significant direct impact on shareholders, as it is a routine tax-related sale rather than a discretionary divestment.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

The transaction reported is a non-discretionary 'sell to cover' for tax obligations related to RSU vesting, which is a routine event for executives. It does not reflect a change in the CFO's outlook on the company's fundamentals or future prospects. Therefore, it provides no new information that would warrant a change in investment recommendation based solely on this filing.

Keywords

Astera Labs, ALAB, Form 4, Insider Trading, Stock Sale, CFO, Michael Truett Tate, Restricted Stock Units, Tax Withholding, Sell to Cover